Lack of correlation between the size of HIV proviral DNA reservoir and the level of immune activation in HIV-infected patients with a sustained undetectable HIV viral load for 10 years

被引:25
作者
Poizot-Martin, Isabelle [1 ]
Faucher, Olivia [1 ]
Obry-Roguet, Veronique [1 ]
Nicolino-Brunet, Corinne [2 ]
Ronot-Bregigeon, Sylvie [1 ]
Dignat-George, Francoise [2 ]
Tamalet, Catherine [3 ]
机构
[1] Aix Marseille Univ, APHM St Marguerite, Serv Immunohematol Clin, Inserm,U912 SESSTIM, Marseille, France
[2] Aix Marseille Univ, APHM Concept, Serv Hematol & Biol Vasc, Marseille, France
[3] Aix Marseille Univ, APHM Timone, Fed Microbiol Hosp, URMITE CNRS IRDUMR 6236, Marseille, France
关键词
HIV-1; Immune activation markers; HIV DNA-proviral; HIV reservoir; ACTIVE ANTIRETROVIRAL THERAPY; T-CELL-ACTIVATION; VIROLOGICAL SUPPRESSION; HIV-1-INFECTED PATIENTS; CD38; EXPRESSION; LYMPHOID-TISSUE; INDIVIDUALS; REPLICATION; RECOVERY; COPIES/ML;
D O I
10.1016/j.jcv.2013.04.007
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: The persistence of HIV residual replication in patients with an undetectable plasma viral load (pVL) may limit immune recovery and facilitate inflammation-induced comorbidities. Objective: The objective was to evaluate any correlation between immune restoration and intracellular [IC] HIV-DNA in cART-treated patients with a sustained undetectable pVL. Study design: This retrospective cross sectional study included 62 patients with a median duration of undetectable pVL of 10.3 years. IC HIV DNA in peripheral mononuclear blood cells (PBMCs) and T cell subsets were measured at the last visit. pVL, CD4(+) and CD8(+) T cell counts were retrospectively collected from the onset of long-term inhibition by antiretroviral treatment. The patients were separated into two groups: 27 non-blippers (sustained pVL < threshold value during all the visits) and 35 blippers (>= 1 episodes of pVL > threshold but < 1000 copies/ml). The median pVL in blippers was 115 copies/ml. Results: The median IC HIV DNA rate was 34 copies/10(6) PBMCs (71% >= 20 copies/10(6) PBMCs) with no significant difference between the groups. The proportion of CD8(+) CD38(+) and CD8(+) DR+ T cells was higher in blipper patients, but the difference was only significant for the CD8(+) DR+ marker (p = 0.036). No correlation was found between markers of immune activation on CD4(+) and CD8(+) T cells and the IC HIV-DNA level. Conclusion: No relation was found between the size of HIV reservoirs and immune activation in patients with sustained undetectable pVL. Mechanisms of immune activation have to be better understood in order to define specific therapeutic interventions. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:351 / 355
页数:5
相关论文
共 22 条
[1]   Higher HIV-1 DNA associated with lower gains in CD4 cell count among patients with advanced therapeutic failure receiving optimized treatment (ANRS 123-ETOILE) [J].
Avettand-Fenoel, Veronique ;
Bouteloup, Vincent ;
Melard, Adeline ;
Fagard, Catherine ;
Chaix, Marie-Laure ;
Leclercq, Pascale ;
Chene, Genevieve ;
Viard, Jean-Paul ;
Rouzioux, Christine .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (10) :2212-2214
[2]   Immunological recovery and antiretroviral therapy in HIV-1 infection [J].
Battegay, M ;
Nuesch, R ;
Hirschel, B ;
Kaufmann, GR .
LANCET INFECTIOUS DISEASES, 2006, 6 (05) :280-287
[3]  
Benito JM, 2004, AIDS RES HUM RETROV, V20, P227, DOI 10.1089/088922204773004950
[4]   Factors influencing peripheral blood mononuclear cell-associated HIV-1 DNA level after long-term suppressive antiretroviral therapy in 236 patients [J].
Burgard, Marianne ;
Boufassa, Faroudy ;
Viard, Jean-Paul ;
Garrigue, Isabelle ;
Ruffault, Annick ;
Izopet, Jacques ;
Vabret, Astrid ;
Descamps, Diane ;
Colson, Philippe ;
Seigneurin, Jean-Marie ;
Rouzioux, Christine .
AIDS, 2009, 23 (16) :2165-2171
[5]   Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy [J].
Chun, Tae-Wook ;
Nickle, David C. ;
Justement, Jesse S. ;
Meyers, Jennifer H. ;
Roby, Gregg ;
Hallahan, Claire W. ;
Kottilil, Shyam ;
Moir, Susan ;
Mican, Joann M. ;
Mullins, James I. ;
Ward, Douglas J. ;
Kovacs, Joseph A. ;
Mannon, Peter J. ;
Fauci, Anthony S. .
JOURNAL OF INFECTIOUS DISEASES, 2008, 197 (05) :714-720
[6]   Relationship Between Residual Plasma Viremia and the Size of HIV Proviral DNA Reservoirs in Infected Individuals Receiving Effective Antiretroviral Therapy [J].
Chun, Tae-Wook ;
Murray, Danielle ;
Justement, J. Shawn ;
Hallahan, Claire W. ;
Moir, Susan ;
Kovacs, Colin ;
Fauci, Anthony S. .
JOURNAL OF INFECTIOUS DISEASES, 2011, 204 (01) :135-138
[7]   Relationship between the size of the human immunodeficiency virus type 1 (HIV-1) reservoir in peripheral blood CD4+ T cells and CD4+:CD8+ T cell ratios in aviremic HIV-1-Infected individuals receiving long-term highly active antiretroviral therapy [J].
Chun, TW ;
Justement, JS ;
Pandya, P ;
Hallahan, CW ;
McLaughlin, M ;
Liu, SY ;
Ehler, LA ;
Kovacs, C ;
Fauci, AS .
JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (11) :1672-1676
[8]   CD4 cell counts of 800 cells/mm3 or greater after 7 years of highly active antiretroviral therapy are feasible in most patients starting with 350 cells/mm3 or greater [J].
Gras, Luuk ;
Kesselring, Anouk M. ;
Griffin, James T. ;
van Sighem, Ard I. ;
Fraser, Christophe ;
Ghani, Azra C. ;
Miedema, Frank ;
Reiss, Peter ;
Lange, Joep M. A. ;
de Wolf, Frank .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 45 (02) :183-192
[9]   T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy [J].
Hunt, PW ;
Martin, JN ;
Sinclair, E ;
Bredt, B ;
Hagos, E ;
Lampiris, H ;
Deeks, SG .
JOURNAL OF INFECTIOUS DISEASES, 2003, 187 (10) :1534-1543
[10]   CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years - The Swiss HIV cohort study [J].
Kaufmann, GR ;
Perrin, L ;
Pantaleo, G ;
Opravil, M ;
Furrer, H ;
Telenti, A ;
Hirschel, B ;
Ledergerber, B ;
Vernazza, P ;
Bernasconi, E ;
Rickenbach, M ;
Egger, M ;
Battegay, M .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (18) :2187-2195